BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 29673738)

  • 41. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
    Imgenberg-Kreuz J; Sandling JK; Almlöf JC; Nordlund J; Signér L; Norheim KB; Omdal R; Rönnblom L; Eloranta ML; Syvänen AC; Nordmark G
    Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.
    Davies R; Hammenfors D; Bergum B; Vogelsang P; Gavasso S; Brun JG; Jonsson R; Appel S
    Eur J Immunol; 2018 Jul; 48(7):1217-1227. PubMed ID: 29604049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity.
    Mohammed S; Vineetha NS; James S; Aparna JS; Babu Lankadasari M; Maeda T; Ghosh A; Saha S; Li QZ; Spiegel S; Harikumar KB
    FASEB J; 2020 Mar; 34(3):4329-4347. PubMed ID: 31971297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Novel Transcript Isoform of TBK1 Negatively Regulates Type I IFN Production by Promoting Proteasomal Degradation of TBK1 and Lysosomal Degradation of IRF3.
    Zhang J; Wu XM; Hu YW; Chang MX
    Front Immunol; 2020; 11():580864. PubMed ID: 33101307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DDX19 Inhibits Type I Interferon Production by Disrupting TBK1-IKKε-IRF3 Interactions and Promoting TBK1 and IKKε Degradation.
    Zhang K; Zhang Y; Xue J; Meng Q; Liu H; Bi C; Li C; Hu L; Yu H; Xiong T; Yang Y; Cui S; Bu Z; He X; Li J; Huang L; Weng C
    Cell Rep; 2019 Jan; 26(5):1258-1272.e4. PubMed ID: 30699353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation.
    Matthys VS; Cimica V; Dalrymple NA; Glennon NB; Bianco C; Mackow ER
    J Virol; 2014 Feb; 88(4):2246-59. PubMed ID: 24390324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yin Yang 1 Dynamically Regulates Antiviral Innate Immune Responses During Viral Infection.
    Zan J; Zhang H; Gu AP; Zhong KL; Lu MY; Bai XX; Zhang JY; Cai J
    Cell Physiol Biochem; 2017; 44(2):607-617. PubMed ID: 29161701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1-IRF3 signaling axis.
    Seo M; Lee SO; Kim JH; Hong Y; Kim S; Kim Y; Min DH; Kong YY; Shin J; Ahn K
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14390-14395. PubMed ID: 27911820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymosin β
    Bosello S; Peluso G; Iavarone F; Tolusso B; Messana I; Faa G; Castagnola M; Ferraccioli G
    Arthritis Res Ther; 2016 Oct; 18(1):229. PubMed ID: 27716395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation.
    Pan M; Yin Y; Hu T; Wang X; Jia T; Sun J; Wang Q; Meng W; Zhu J; Dai C; Hu H; Wang C
    Autophagy; 2023 Feb; 19(2):440-456. PubMed ID: 35543189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
    Jara D; Carvajal P; Castro I; Barrera MJ; Aguilera S; González S; Molina C; Hermoso M; González MJ
    Front Immunol; 2021; 12():685837. PubMed ID: 34149728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.
    Paradowska-Gorycka A; Wajda A; Stypinska B; Walczuk E; Rzeszotarska E; Walczyk M; Haladyj E; Romanowska-Prochnicka K; Felis-Giemza A; Lewandowska A; Olesińska M
    Clin Exp Immunol; 2021 Apr; 204(1):49-63. PubMed ID: 33336388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
    Yiu G; Rasmussen TK; Tsai BL; Diep VK; Haddon DJ; Tsoi J; Miller GD; Comin-Anduix B; Deleuran B; Crooks GM; Utz PJ
    Front Immunol; 2022; 13():833636. PubMed ID: 35185925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmacytoid dendritic cells and interferon-alpha in Aicardi-Goutières syndrome.
    van Heteren JT; van der Knaap MS; Poll The BW; Kuijpers TW
    Neuropediatrics; 2007 Dec; 38(6):269-75. PubMed ID: 18461501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.
    Zheng L; Yu C; Zhang Z; Yang C; Cai X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):661-8. PubMed ID: 19426920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK; Lee JY; Park SH; Cho ML; Min SY; Park SH; Kim HY; Cho YG
    Arthritis Res Ther; 2008; 10(2):R29. PubMed ID: 18321389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses.
    Deng Y; Zheng Y; Li D; Hong Q; Zhang M; Li Q; Fu B; Wu L; Wang X; Shen W; Zhang Y; Chang J; Song K; Liu X; Shang S; Cai G; Chen X
    EBioMedicine; 2021 Aug; 70():103477. PubMed ID: 34284174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.